Document Detail

The treatment of bovine collagen allergy with cyclosporin.
MedLine Citation:
PMID:  10193976     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Bovine collagen is currently the most common substance used in soft-tissue augmentation. Although patients should undergo routine skin testing for allergy to bovine collagen prior to treatment, hypersensitivity reactions may rarely still occur. Previously, there have been no reliable methods of treatment for these reactions, and physicians could only reassure patients that the reaction would slowly disappear. OBJECTIVE. The use of oral cyclosporin in a patient with hypersensitivity to bovine collagen was evaluated. METHODS: A patient with an allergic reaction to implanted bovine collagen was started on cyclosporin 175 mg p.o. bid (5 mg/kg/day) after no improvement was seen after treatment with oral and topical steroids. The cyclosporin was started on Day 23 of the allergic reaction. RESULTS: Improvement in the itching and redness was noted by Day 28 of the allergic reaction, and complete clinical resolution of the allergic reaction was noted on Day 41. On Day 47, the cyclosporin was stopped without recurrence of symptoms. The patient did not experience side effects from cyclosporin, and her blood pressure and renal function remained normal. CONCLUSION: This case report shows that oral cyclosporin A may be a safe and effective treatment for bovine collagen hypersensitivity.
L S Baumann; F Kerdel
Related Documents :
24858326 - Coronary artery abnormalities in kawasaki disease.
18050296 - Steroid-refractory ulcerative colitis: predictive factors of response to cyclosporine a...
12817066 - Therapy-resistant focal and segmental glomerulosclerosis.
3381266 - Treatment of endogenous uveitis with cyclosporine a.
23823056 - Cervical disk arthroplasty versus acdf for preoperative reducible kyphosis.
8554746 - Implant-retained prosthetic rehabilitation of orbital defects.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]     Volume:  25     ISSN:  1076-0512     ISO Abbreviation:  Dermatol Surg     Publication Date:  1999 Mar 
Date Detail:
Created Date:  1999-04-30     Completed Date:  1999-04-30     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9504371     Medline TA:  Dermatol Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  247-9     Citation Subset:  IM    
University of Miami Department of Dermatology, Florida, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Collagen / adverse effects,  immunology*
Cyclosporine / administration & dosage,  therapeutic use*
Hypersensitivity / drug therapy*,  etiology
Immunosuppressive Agents / administration & dosage,  therapeutic use*
Surgery, Plastic / adverse effects*
Reg. No./Substance:
0/Immunosuppressive Agents; 59865-13-3/Cyclosporine; 9007-34-5/Collagen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing.
Next Document:  Possible hazards of cryogen use with pulsed dye laser. A case report and summary.